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Objective: The aim of this study was to develop standard-
ized scores and scoring tables for test performance in 
healthy adolescents for the Measurement and Treatment 
Research to Improve Cognition in Schizophrenia 
(MATRICS) Consensus Cognitive Battery (MCCB) for 
each year from 11 to 19 years of age, by sex, with T scores 
and percentile ranks. Methods: A total of 502 healthy par-
ticipants (aged 11–19 years) from 7 cohorts from Ireland, 
Norway, Sweden, and United States, were included in this 
multisite study. Regression-predicted means for the MCCB 
tests, except the social cognition subtest, were calculated 
using the MCCB test scores as outcome variables and age, 
age2, sex, age × sex as predictors. The regression-predicted 
means for each combination of age and sex were added with 
the residuals from the entire cohort to yield the expected 
distribution of that group. Age effects were examined using 
regression models with age and age2 as predictors. Sex dif-
ferences were examined using Student’s t-tests. Results: 
Significant positive age effects were found for all tests, 
except for the Brief Visuospatial Memory Test, revised 
(BVMT-R; measure of visual learning). Females per-
formed significantly better than males on BACS Symbol 
coding (measure of speed of processing) and BVMT-R, 
while males performed significantly better than females on 
NAB Mazes (measure of reasoning and problem solving). 
Based on the regression-predicted distributions of scores, 
19 standardized scoring tables for each test and domain 
were created. Conclusions: With the results from this study, 
we have developed an accessible standardized data set of 
healthy adolescent test performance for the MCCB.
Key words:  early-onset/psychosis/schizophrenia/neuroc
ognition/neuropsychology
Introduction
The Measurement and Treatment Research to Improve 
Cognition in Schizophrenia (MATRICS) Consensus 
Cognitive Battery (MCCB) is a hybrid cognitive test 
battery developed for use in clinical treatment trials for 
schizophrenia.1 The MCCB is a result of the MATRICS 
initiative from the US National Institute of Mental 
Health (NIMH).2 It includes 10 tests divided into 7 
domains: Speed of processing, Attention/vigilance, 
Working memory, Verbal learning, Visual learning, 
Reasoning and problem solving, and Social cognition. In 
adults, the MCCB has shown good reliability and valid-
ity, and minimal practice effects.2 The MCCB has been 
standardized and co-normed for adults aged 20–59 years 
by the developers of the battery.1 The battery has also 
been used for assessment of cognition in children3 and 
adolescents.4 However, despite the success and popularity 
of the MCCB to date, norms have not yet been deter-
mined for children or adolescents.
Adolescence is a critical period for maturation of 
neurobiological processes that underlie higher cognitive 
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functions, and social and emotional behavior.5,6 The 
expansion of standardized MCCB scores to adolescence 
is important because this period of life is associated 
with increased incidence of mental disorders, includ-
ing schizophrenia,7 and because it provides a method 
to examine patterns of performance between tests and 
domains included in the MCCB. Previous reports of 
healthy adolescent test performance using the MCCB3,8–10 
have not provided sufficient differentiation between age 
and sex strata to develop standardized scoring tables. As 
these studies have used age strata of 2 or more years, have 
relatively small sample sizes in each age group and lack 
differentiation by sex, their usefulness as norms for scor-
ing of individual test results is limited.
The aim of this study was to develop standardized 
scores and scoring tables for each test and domain in the 
MCCB, with associated T scores and percentile ranks, 
based on regression-predicted scores of healthy test per-
formance, within each year, stratified by sex, in the ado-
lescent period from 11 to 19 years of age.
Methods
Relevant research groups were identified by database 
searching and by contacting researchers that could be 
aware of other groups with MCCB data for healthy 
children and adolescents. Principal investigators from 
11 research groups that had collected MCCB data from 
healthy adolescents were contacted and invited to partici-
pate in this multisite study.
Participants
A total of 502 healthy participants between the ages 11 
and 19 years were included. These comprised 7 cohorts 
from Ireland (n  =  131), Norway (n  =  178), Sweden 
(n = 26), and the United States (n = 167). In 5 out of 7 
cohorts, the participants had been recruited as healthy 
controls (HC) to match clinical psychosis samples within 
their respective studies. Thus, the combined cohort of 502 
participants may be regarded as a multinational healthy 
control sample rather than a population-based norma-
tive sample. Exclusion criteria for mental disorders were 
part of the protocols and are described below. All par-
ticipants were screened for Axis I  disorders, according 
to the Diagnostic and statistical manual of mental disor-
ders, fourth edition text revision (DSM-IV-TR). In each 
of the cohorts, written informed consent was obtained 
from the participants, parents, or guardians, according 
to the guidelines in the respective countries. All minor 
participants provided assent alongside parental written 
informed consent. All studies were approved by their local 
ethical committees and conducted in accordance with the 
Helsinki Declaration. For detailed information about the 
independent cohorts and the combined cohort, see table 1.
Study 1: The Thematically Organized Psychosis Study for 
Youth (YTOP), University of Oslo, Norway 
Sixty-seven participants were recruited as HC to the study. 
The participants were recruited from the Norwegian pop-
ulation register living in the Oslo area and matched for 
age and sex to ensure similar distribution as the included 
patients. Participants were excluded if  they currently met 
criteria for, or previously had received treatment for an 
Axis I disorder, illicit substance use or alcohol depend-
ence, IQ < 70, head injury with loss of consciousness ≥10 
minutes, a medical illness that could affect brain func-
tioning, or first-degree relatives with a psychotic or bipo-
lar disorder.
Study 2: The Early-Onset Study (EOS), University of 
Oslo, Norway 
Eighty-three participants were recruited as HC to 
the study. The participants were recruited from the 
Norwegian population register living in the Oslo area and 
from selected schools. They were matched for age and sex 
to ensure similar distribution as the included patients. 
Participants were excluded if  they currently or previously 
had met criteria for an Axis I disorder, illicit substance 
use or alcohol dependence, IQ < 70, head injury with loss 
of consciousness ≥30 minutes, a medical illness that could 
affect brain functioning, or first-degree relatives with a 
psychotic or bipolar disorder.
Study 3: The Thematically Organized Psychosis (TOP) 
Study, Oslo University Hospital and University of Oslo, 
Norway 
Twenty-eight participants were recruited as HC to the 
study. The participants were recruited by random sam-
pling from the Norwegian population register living in 
the Oslo area. Participants were excluded if  they currently 
or previously had met criteria for an Axis I disorder, illicit 
substance use or alcohol dependence, IQ < 70, hospital-
ized head injury, a medical illness that could affect brain 
functioning, or first-degree relatives with a major depres-
sive disorder, psychotic, or bipolar disorder.
Study 4: The Stockholm Child and Adolescent Psychosis 
Study (SCAPS), Karolinska Institutet, Sweden 
Twenty-six participants were recruited as HC to the study. 
The participants were recruited from the Swedish popula-
tion register living in the Stockholm area and matched for 
age to ensure similar distribution as the included patients. 
Participants were excluded if  they currently met criteria 
for an Axis I disorder, or previously had met criteria for 
a psychotic or bipolar disorder, illicit substance use or 
alcohol dependence, head injury with loss of conscious-
ness ≥3 minutes, a medical illness that could affect brain 
functioning, or first-degree relatives with a psychotic 
or bipolar disorder. All participants attended regular 
schools without any support measures and were therefore 
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considered to be within the normal IQ range. No other 
intelligence assessment was performed.
Study 5: The Adolescent Brain Development (ABD) 
Study, Royal College of Surgeons in Ireland 
One hundred thirty-one community-based participants 
were recruited from schools in Dublin and surrounding 
counties.3 The purpose of  the study was to investigate 
the prevalence of  psychotic symptoms and general psy-
chopathology, as well as associated cognitive and neuro-
biological abnormalities in an epidemiological sample. 
For the purposes of  the current analyses, participants 
were excluded if  they currently met criteria for an Axis 
I disorder, illicit substance use or alcohol dependence, 
or previously had met criteria for a psychotic or bipo-
lar disorder, a medical illness that could affect brain 
functioning, or first-degree relatives with a psychotic or 
bipolar disorder.
Study 6: The Comprehensive Assessment of 
Neurodevelopment in Youth (CANDY) Study, Zucker 
Hillside Hospital, NY, United States 
One hundred twenty participants were recruited to the 
study from the general population of a region bridg-
ing urban New York City with suburban Long Island. 
Participants were recruited through newspaper and 
Internet advertisements as well as posted flyers seeking 
healthy children and adolescents between the ages of 8 
and 18 for a study aimed to understand normal brain 
development.19 Participants were excluded if  they cur-
rently or previously had met criteria for an Axis I disor-
der, illicit substance use or alcohol dependence, IQ < 70, 
head injury with loss of consciousness (for any amount 
of time), a medical illness that could affect brain func-
tioning, taking medications with known cognitive effects, 
or first-degree relatives with a major depressive disorder, 
psychotic, or bipolar disorder.
Study 7: The Multimodal Assessment of 
Neurodevelopmental Disorders (MEND) Study, Zucker 
Hillside Hospital, NY, United States 
Forty-seven participants were recruited as HC to the 
study. The participants were recruited from the general 
population via advertisement, recommendations from 
other participants and through outreach activities to 
educational organizations in the New York City area. 
Participants were excluded if  they currently or previously 
had met criteria for an Axis I disorder, illicit substance 
use or alcohol dependence, IQ < 70, head injury with loss 
of consciousness (for any amount of time), a medical ill-
ness that could affect brain functioning, taking medica-
tions with known cognitive effects, conditions that were 
contraindications of MRI (claustrophobia, pregnancy, 
etc.), or first-degree relatives with a major depressive dis-
order, psychotic, or bipolar disorder. The CPT-IP test 
was not included in this study.
Neurocognitive Measures
Nine out of 10 tests from the MCCB were included. The 
Social cognition domain (measured with the MSCEIT 
Managing emotions test20) was not part of the assess-
ment in any of the cohorts and was therefore excluded 
from this study. The 9 included tests covered 6 neuro-
cognitive domains: (1) Speed of processing, measured 
with the BACS Symbol coding,21 Trail making test, part 
A  (TMT-A),22 and Category fluency: Animal naming,23 
(2) Attention/vigilance, measured with the Continuous 
performance test, identical pairs (CPT-IP),24 (3) Working 
memory, measured with the WMS-III Spatial span25 and 
Letter-number span,26 (4) Verbal learning, measured with 
the Hopkins verbal learning test, revised (HVLT-R),27 
(5) Visual learning, measured with the Brief  visuospa-
tial memory test, revised (BVMT-R),28 and (6) Reasoning 
and problem solving, measured with the NAB Mazes.29 
The HVLT-R test was originally validated for ages ≥16. 
However, as the stimulus list consists of simple words and 
previously has been used in children and adolescents,10,30,31 
we considered the original test appropriate for our age 
groups. In the Norwegian and Swedish cohorts, licensed 
translated versions of the MCCB were used (see32 and 
www.matricsinc.org/mccb).
Statistical Analyses
The main strategy for calculating regression-predicted 
scores for the age and sex groups is described in Iverson 
et al.33 The general principle is that for each test, the vari-
ation in test scores present in the total age range is used to 
predict the distribution of scores for each combination of 
age (ie, 9 age groups from 11 to 19 years) and sex, result-
ing in a total of 18 groups. To achieve this, regression 
models are first fitted to the entire cohort. The regression-
predicted means for each age and sex group are then sum-
mated with the residuals from the entire cohort, yielding 
the regression-predicted distribution of scores for that 
specific group.
Validation of Statistical Assumptions 
When multiple regression is used for prediction of scores, 
it is crucial that the statistical assumptions are carefully 
investigated.34,35 Thus, we initially examined the normal-
ity of whole-sample distributions for the raw scores of 
each of the 9 MCCB tests before analysis. If  the distribu-
tions showed an absolute value of skewness of more than 
0.8 they were transformed. Furthermore, we examined 
homogeneity of variance using one-way ANOVA mod-
els with Levene’s test. Tests showing significant group 
differences in scores were transformed to achieve equal 
variances across age groups. Lastly, for each regression 
model under analysis we examined outliers, defined as 
±3 standard deviations (SD) from the mean, and their 
potential influence on the model to ensure good model 
fit. Influence were evaluated using values for leverage 
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(≤0.2 considered to be safe36) and Cook’s distance (<1 
considered to be safe37).
Effects of Age and Sex 
Previous studies have shown nonlinear development of 
cognitive performance during childhood and adoles-
cence.9,10,38 Therefore, regression models including age 
and age2 as predictors were used to describe the effects of 
age on test performance. Sex differences were investigated 
using Student’s t-tests. All tests were 2-tailed.
Standardization of Score Distributions 
The following standardization procedure was performed: 
(1) Curve estimations (linear, logarithmic, and quad-
ratic) of the age slope for each test were performed to 
identify the best fit for the data. Including quadratic 
terms in the model provided the best fit for all tests. (2) 
Multiple regression analyses were then performed with 
the MCCB raw or transformed scores as outcome vari-
able and age, age2, sex, age × sex as predictor variables. 
The unstandardized residuals and the unstandardized 
predicted scores (representing the regression-predicted 
mean for that age and sex) from each regression model 
were saved. (3) The regression-predicted means for each 
of the 18 groups were summated with the unstandardized 
residuals from the entire cohort (representing the var-
iation relative to each group’s mean score), resulting in 
the regression-predicted distributions of scores for each 
age group. These distributions were thereafter validated 
by comparing them with the MCCB raw scores to ensure 
that the predicted models were adequate fits of the orig-
inal raw data. (4) The regression-predicted distributions 
were transformed to standard scores (z scores) using the 
SPSS standardization function, and further transformed 
to T scores using the formula 50 + (10 × [z score]). For 
the TMT-A test the scores were reversed so that higher 
scores were equal to better performance. (5) In domains 
containing more than 1 subtest (ie, speed of processing 
and working memory) and for the global cognition score 
(based on the 9 included tests), composite scores were cal-
culated by summating the T scores of relevant tests and 
transforming the sum score to standard scores using the 
same procedure as described above. (6)  The regression-
predicted scores were rounded to nearest integer. Based 
on these distributions 19 detailed scoring tables were 
developed with associated T scores and percentile ranks. 
Italicized test scores in the scoring tables indicate that the 
scores are based on the regression-predicted means rather 
than based on individual scores from the participant dis-
tributions. All statistical analyses were performed in IBM 
SPSS Statistics for Windows, Version 24.
Results
Examining the normality of distributions of the MCCB 
raw scores, 3 tests were regarded as skewed and were 
transformed using formulas with best fit to the data. The 
BVMT-R and NAB Mazes tests had negatively skewed 
distributions and were transformed using reflect and 
square root. The TMT-A test had a positively skewed dis-
tribution and was transformed using natural logarithm. 
No notable deviation from normality was observed after 
completed transformations. Examination of homogene-
ity of variance indicated unequal variance between age 
groups for the WMS-III Spatial span, F(8, 493) = 1.99, 
P = .046, which was transformed using natural logarithm. 
Examination of outliers showed less than 1% outliers for 
all tests, except for Animal naming (1.2%). Leverage val-
ues were below .03 and Cook’s distance values were below 
.07 for all tests, indicating little influence of extreme cases 
over the parameters of the model.
Age and Sex Effects
Examination of age effects on test performance was per-
formed using regression models with age and age2 as pre-
dictors. The overall models showed significant positive 
age effects for all tests (P < .001), except for the BVMT-R. 
Examination of the separate predictors revealed quad-
ratic associations with age for 6 tests (HVLT-R, NAB 
Mazes, WMS-III Spatial span, TMT-A, BACS Symbol 
coding, Animal naming, all P-values for age2 < .005), lin-
ear associations with age for 2 tests (Letter-number span, 
CPT-IP, all P-values for age < .001) and no significant 
association with age for one test (BVMT-R). We found sig-
nificant sex differences for 3 tests, using independent sam-
ples t-tests. Females performed significantly better than 
males on BACS Symbol coding (MF = 58.6, SD = 10.5 
vs MM  =  56.2, SD  =  11.9), t(499)  =  2.4, P  =  .02, and 
BVMT-R (MF = 28.5, 95% CI = [27.9, 29.1] vs MM = 27.3, 
95% CI = [26.6, 28.0]), t(495) = 2.57, P = .01. Males per-
formed significantly better than females on NAB Mazes 
(MM  =  21.4, 95% CI  =  [20.8, 21.9] vs MF  =  20.3, 95% 
CI = [19.7, 21.0]), t(497) = 2.39, P = .02.
Regression-Predicted and Unadjusted Means
The multiple regression models using age, age2, sex, age 
× sex as predictors, which were included for all tests, 
statistically significantly predicted performance on 8 
out of 9 tests (BACS Symbol coding, F(4, 496) = 53.42, 
P < .001, adj. R2  =  .295, standard error of the esti-
mate  (SEE) = 9.43; Animal naming, F(4, 481) = 21.84, 
P < .001, adj. R2  =  .147, SEE  =  5.17; TMT-A, F(4, 
479)  =  57.45, P < .001, adj. R2  =  .319, SEE  =  .31; 
CPT-IP, F(4, 417)  =  36.33, P < .001, adj. R2  =  .251, 
SEE  =  .60; WMS-III Spatial span, F(4, 497)  =  14.96, 
P < .001, adj. R2 = .100, SEE = .19; Letter-number span, 
F(4, 497) = 14.61, P < .001, adj. R2 = .098, SEE = 2.94; 
HVLT-R, F(4, 497)  =  6.35, P < .001, adj. R2  =  .041, 
SEE = 4.13; NAB Mazes, F(4, 494) = 29.73, P < .001, 
adj. R2 = .187, SEE = .88). No significant association was 
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found for the BVMT-R, F(4, 492) = 1.85, p < .12, adj. 
R2 = .007, SEE = .83). The regression models are shown 
in figure 1. The regression-predicted means and SD for 
males and females are presented in table 2.
To compare the regression-predicted means with the 
original raw scores, we calculated unadjusted means and 
SD for each age and sex. The unadjusted means and SD 
for males and females are presented in tables 3 and 4.
Based on the regression-predicted distributions of 
scores, a total of 19 standardized scoring tables were 
made. These tables are found in the supplemental mate-
rial. They include regression-predicted distributions of 
test scores and domain scores, with associated T scores 
and percentile ranks, for each age and sex.
Discussion
We present regression-predicted and unadjusted means of 
healthy adolescent performance on the MCCB, for each 
year from 11 to 19  years, stratified by sex. Based on the 
regression-predicted distributions of scores we present 19 
standardized scoring tables with associated T scores and 
percentile ranks. To date, all studies of the MCCB in healthy 
adolescents have reported on just one or, at most, 2 sam-
ples. This study represents the largest analysis of MCCB in 
healthy adolescents to date, combining data from 7 cohorts 
with more than 500 participants. Although our resulting 
scoring tables do not represent population-based norms, ex-
pansion of standardized scores to adolescence is essential as 
this stage in life is an important period for cognitive develop-
ment5,6 and for the emergence of mental disorders.7
We found significant quadratic age effects in 6 out of 
9 tests, covering the Speed of processing, Verbal learning 
and Reasoning and problem solving domains, and for the 
WMS-III Spatial span test, included in the Working mem-
ory domain. This indicates that performance on these tests 
improves at the onset of puberty and levels off during late 
adolescence. We found significant linear age effects for the 
Attention/vigilance domain and the Letter-number span 
test, included in the Working memory domain, indicat-
ing a steady increase in test performance with higher age. 
We did not find significant age effects for the test used to 
measure Visual learning, suggesting that performance on 
this test is stable across the adolescent period.
Fig. 1. Regression models of test performance for each neurocognitive test included in the MCCB from 11 to 19 years of age, separated 
by sex, and standardized to T scores.
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Our results agree with Waber et al,38 who found quad-
ratic age effects in most cognitive tests included in the 
US National Institute of  Health’s study of  normal brain 
development from age 6 to 18 years. Our results are also 
in agreement with Gur et al,39 who found significant age 
effects for the cognitive tests in their population-based 
sample of  children from age 8 to 21 years, except for the 
visual and verbal memory tests. They suggested that the 
missing age effects in these tests could be a result of  early 
maturation in brain structures associated with learn-
ing and memory. Gur et al39 also suggested that ceiling 
effects might have occurred in the verbal test included in 
their test battery due to modifications in the word reada-
bility level for the youngest age group, which can poten-
tially explain the difference from our findings on verbal 
learning.
We found significant sex differences in the Reasoning 
and problem solving domain, with males performing bet-
ter than females. Females performed better in the Visual 
learning domain and on the BACS Symbol coding test, 
included in the Speed of processing domain. These find-
ings are in keeping with Waber et al,38 who showed that, 
as a group, males performed better on perceptual tests, 
while females performed better on processing speed 
tests. Our results are also partly in keeping with data 
from Kern et al1 on healthy adult MCCB performance, 
which showed that males performed significantly better 
than females in the Reasoning and problem solving and 
Working memory domains, while females performed bet-
ter in the Verbal learning domain.
Visual inspection of figure  1 shows that for most 
tests females perform better than males during early 
Table 2. MCCB Subtest Regression-Predicted Means by Age and Sex
Age: Regression-Predicted Means (SD)
MCCB Tests Sex 11 12 13 14 15 16 17 18 19
BACS Symbol coding Male 44.63 49.77 54.06 57.50 60.10 61.84 62.73 62.78 61.97
(9.39) (9.39) (9.39) (9.39) (9.39) (9.39) (9.39) (9.39) (9.39)
(N = 501) Female 48.47 53.01 56.71 59.55 61.55 62.70 62.99 62.44 61.04
(9.39) (9.39) (9.39) (9.39) (9.39) (9.39) (9.39) (9.39) (9.39)
Animal naming Male 18.99 20.63 22.04 23.20 24.13 24.82 25.28 25.50 25.48
(5.15) (5.15) (5.15) (5.15) (5.15) (5.15) (5.15) (5.15) (5.15)
(N = 486) Female 19.40 20.86 22.09 23.09 23.84 24.36 24.64 24.69 24.50
(5.15) (5.15) (5.15) (5.15) (5.15) (5.15) (5.15) (5.15) (5.15)
Trail making test A Male 46.06 39.17 34.17 30.59 28.09 26.47 25.59 25.38 25.83
(14.90) (12.67) (11.05) (9.90) (9.09) (8.56) (8.28) (8.21) (8.36)
(N = 484) Female 43.18 37.06 32.64 29.50 27.35 26.01 25.38 25.42 26.11
(13.97) (11.99) (10.56) (9.54) (8.85) (8.41) (8.21) (8.22) (8.45)
CPT-IP d′ Male 1.50 1.69 1.86 2.03 2.18 2.33 2.46 2.59 2.70
(.60) (.60) (.60) (.60) (.60) (.60) (.60) (.60) (.60)
(N = 422) Female 1.65 1.79 1.92 2.03 2.14 2.24 2.32 2.40 2.47
(.60) (.60) (.60) (.60) (.60) (.60) (.60) (.60) (.60)
WMS-III Spatial span Male 14.81 15.75 16.58 17.26 17.79 18.15 18.32 18.31 18.10
(2.73) (2.91) (3.06) (3.18) (3.28) (3.35) (3.38) (3.38) (3.34)
(N = 502) Female 15.72 16.50 17.15 17.64 17.96 18.09 18.03 17.79 17.38
(2.90) (3.04) (3.16) (3.25) (3.31) (3.34) (3.33) (3.28) (3.21)
Letter-number span Male 13.01 13.59 14.12 14.60 15.02 15.39 15.71 15.97 16.18
(2.93) (2.93) (2.93) (2.93) (2.93) (2.93) (2.93) (2.93) (2.93)
(N = 502) Female 12.96 13.46 13.90 14.29 14.63 14.92 15.15 15.33 15.45
(2.93) (2.93) (2.93) (2.93) (2.93) (2.93) (2.93) (2.93) (2.93)
HVLT-R Male 24.49 25.40 26.12 26.67 27.04 27.23 27.23 27.06 26.71
(4.12) (4.12) (4.12) (4.12) (4.12) (4.12) (4.12) (4.12) (4.12)
(N = 502) Female 25.50 26.28 26.89 27.31 27.56 27.62 27.51 27.21 26.74
(4.12) (4.12) (4.12) (4.12) (4.12) (4.12) (4.12) (4.12) (4.12)
BVMT-R Male 26.50 26.66 26.77 26.82 26.83 26.79 26.69 26.55 26.35
(5.38) (5.34) (5.31) (5.30) (5.30) (5.31) (5.33) (5.37) (5.42)
(N = 497) Female 27.28 27.52 27.72 27.86 27.96 28.01 28.01 27.96 27.87
(5.18) (5.11) (5.06) (5.01) (4.99) (4.97) (4.97) (4.99) (5.01)
NAB Mazes Male 16.53 18.48 19.93 21.00 21.73 22.20 22.43 22.45 22.25
(5.70) (5.13) (4.65) (4.27) (3.99) (3.79) (3.69) (3.69) (3.77)
(N = 499) Female 15.07 17.10 18.63 19.75 20.53 21.01 21.22 21.20 20.93
(6.10) (5.54) (5.08) (4.72) (4.45) (4.27) (4.19) (4.20) (4.30)
Note: Different number of participants in the tests is due to missing data for individual participants, except for the CPT-IP test which 
was not included in one of the studies.
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adolescence, and that this sex difference evens out by mid/
late adolescence. For the CPT-IP and the WMS Spatial 
span tests, males showed continued increase in perfor-
mance. This pattern may reflect the fact that females, on 
average, enter puberty earlier than males,40 a factor which 
is known to impact upon brain and cognitive develop-
ment.41,42 Females, eg, typically reach peak gray matter 
thickness 1–2 years earlier than males.43 During puberty, 
Table 4. MCCB Subtest Unadjusted Means by Age for Females
Age: Unadjusted Means (SD)
MCCB Tests
11 12 13 14 15 16 17 18 19
n = 29 n = 40 n = 15 n = 31 n = 23 n = 27 n = 40 n = 31 n = 19
BACS Symbol coding 49.38 51.33 56.47 60.77 64.70 61.04 61.85 63.35 60.84
(N = 255) (8.75) (8.49) (6.09) (11.08) (9.78) (10.35) (8.28) (9.06) (9.34)
Animal naming 19.38 21.13 20.47 22.55 24.65 25.65 24.31 25.16 23.39
(N = 246) (4.59) (5.07) (3.56) (5.23) (5.57) (4.91) (5.61) (4.95) (3.53)
Trail making test A 44.50 37.87 29.21 29.29 22.89 27.66 25.42 26.20 26.60
(N = 247) (13.90) (9.18) (9.13) (9.66) (5.83) (8.83) (7.18) (8.88) (9.56)
CPT-IP d′ 1.70 1.76 1.83 2.02 2.27 2.19 2.37 2.33 2.49
(N = 214) (.58) (.64) (.73) (.58) (.54) (.51) (.54) (.52) (.43)
WMS-III Spatial span 15.72 16.18 17.93 17.77 18.30 17.93 17.78 17.48 17.84
(N = 255) (2.91) (3.15) (3.06) (3.01) (3.28) (3.14) (2.55) (3.49) (3.66)
Letter-number span 13.31 13.45 14.07 13.48 14.48 15.30 15.25 15.58 15.16
(N = 255) (2.55) (3.21) (2.76) (3.45) (3.36) (3.59) (2.47) (2.85) (2.67)
HVLT-R 26.55 26.05 25.27 26.19 28.48 28.00 27.55 27.84 25.95
(N = 255) (3.65) (4.47) (3.97) (3.47) (4.45) (4.12) (3.26) (3.98) (4.64)
BVMT-R 27.48 27.75 27.13 27.55 28.65 26.67 27.93 29.03 28.05
(N = 255) (6.14) (6.10) (3.46) (3.82) (4.07) (5.70) (4.50) (3.83) (5.52)
NAB Mazes 13.69 16.90 19.60 21.87 21.39 20.19 20.28 20.70 21.84
(N = 254) (5.18) (4.95) (5.47) (4.09) (4.15) (4.39) (4.98) (4.24) (4.48)
Note: Different number of participants in the tests is due to missing data for individual participants, except for the CPT-IP test which 
was not included in one of the studies.
Table 3. MCCB Subtest Unadjusted Means by Age for Males
Age: Unadjusted Means (SD)
MCCB Tests
11 12 13 14 15 16 17 18 19
n = 42 n = 41 n = 15 n = 17 n = 22 n = 29 n = 26 n = 35 n = 20
BACS Symbol coding 46.26 46.73 56.40 60.75 58.18 61.72 63.04 63.23 61.50
(N = 246) (7.64) (9.09) (10.43) (7.74) (8.06) (11.65) (10.96) (11.13) (8.61)
Animal naming 18.67 21.02 24.13 23.35 22.32 24.08 24.38 27.24 24.85
(N = 240) (3.77) (4.68) (6.00) (4.74) (5.61) (5.09) (7.87) (5.44) (5.41)
Trail making test A 44.00 41.31 30.99 26.45 30.98 27.37 27.82 25.26 24.84
(N = 237) (12.84) (12.11) (9.97) (6.32) (9.33) (9.42) (9.32) (9.21) (13.64)
CPT-IP d′ 1.46 1.73 1.83 2.17 2.10 2.32 2.44 2.56 2.78
(N = 208) (.77) (.58) (.91) (.35) (.51) (.78) (.46) (.63) (.44)
WMS-III Spatial span 14.79 15.56 17.60 17.47 17.18 17.90 18.42 18.60 18.25
(N = 247) (2.35) (2.96) (3.54) (3.50) (3.65) (3.15) (3.64) (3.23) (4.90)
Letter-number span 12.55 13.90 15.40 14.53 14.23 15.55 16.04 15.77 16.15
(N = 247) (2.39) (3.03) (4.64) (2.50) (2.58) (2.34) (2.68) (2.97) (3.22)
HVLT-R 23.69 26.46 26.27 27.18 25.50 26.69 28.77 27.31 25.70
(N = 247) (5.03) (3.61) (5.32) (2.88) (4.77) (3.75) (4.78) (3.29) (4.09)
BVMT-R 25.05 27.38 28.27 29.67 26.25 26.79 25.81 26.29 26.40
(N = 242) (6.30) (4.73) (5.82) (3.37) (6.15) (4.66) (5.11) (5.93) (5.72)
NAB Mazes 16.71 18.34 22.47 20.00 19.82 21.45 22.96 23.09 22.75
(N = 245) (5.47) (5.22) (4.00) (3.67) (5.41) (4.65) (3.49) (3.13) (2.51)
Note: Different number of participants in the tests is due to missing data for individual participants, except for the CPT-IP test which 
was not included in one of the studies.
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the prefrontal cortex, associated with attention and work-
ing memory,5 goes through notable change.44,45 Earlier 
cognitive maturation in females may therefore explain 
part of the observed age trajectories in figure 1.
Strengths and Limitations
The main strength of this study is the large sample size of 
more than 500 adolescents from 7 cohorts in 4 countries. 
With this sample size, we were able to make standardized 
scores for each year between the ages of 11–19 instead 
of using age strata of 2 or more years, as has previously 
been done. Second, using data from multiple independ-
ent cohorts decreases the chances of confounding effects 
from one site. A third strength is the use of regression-
predicted means in combination with the unstandardized 
residuals from the total sample in the development of the 
standardized scoring tables. Using this method, the dis-
tribution of scores for each year from 11 to 19 years of 
age, stratified by sex, were built on the substantial size 
of the entire cohort, reducing the influence of extreme 
scores while upholding the broad range in variation.
The main limitation of this study is the possible site 
differences between the cohorts. The combined cohort 
does not represent a particular country or demographic 
population strata. Instead it represents a multinational 
control group for the MCCB. In this regard, several factors 
need consideration: The ABD cohort was the only cohort 
recruited in an epidemiological setting, whereas the other 
cohorts were recruited as part of clinical studies, using 
various convenience methods (see cohort descriptions 
for more information). Recruitment of healthy controls 
might thus have been influenced by factors such as 
housing location, subscription to newspapers, and friends, 
in which potential sampling biases cannot be ruled out. 
Other demographic differences in and between sites 
(eg, socioeconomic status, language, culture, ethnicity, 
education level, school systems, or teaching methods) were 
not specifically controlled for in our analyses. It was not 
possible to fully determine how site differences might have 
affected variation in cognitive performance since age and 
other inclusion or exclusion criteria differed between the 
cohorts. When comparing global cognition between 
the cohorts we found a significant difference between 
the EOS and the CANDY cohorts (table  1). However, 
when investigating homoscedasticity, there were no 
significant differences in variance for 7 of the 9 tests, 
indicating that the variability in cognitive performance 
for most tests was equal between the cohorts. To our 
knowledge, site differences that would be expected to 
impact cognitive performance substantially and thereby 
to cause systematic bias, have not been identified for any 
of the cohorts. A second limitation is the screening and 
exclusion of participants with current mental disorders. 
This might have resulted in an above average healthy 
group of participants which is not representative of the 
adolescent population at large. The average IQ in the 
combined cohort was 105, slightly above the normative 
average of 100,46 which may potentially have caused a 
bias toward elevated scores. A third limitation is that illicit 
substance use and alcohol dependence were investigated 
by interviews without confirmation from urine or hair 
samples. Consequently, we cannot rule out that drugs 
might have influenced test performance for some of the 
participants. A  fourth limitation is differences in test 
administration. Due to the multisite nature of the study, it 
was not possible to ensure that the tests were administered 
in the recommended test order2 or whether additional 
tests, not part of the MCCB, were included. Such factors 
may conceivably have caused differences between sites in 
test performance due to fatigue, interference, or reduced 
motivation. A  fifth limitation is that the cohorts had 
different number of participants, in which larger cohorts 
have had greater influence on the results. A sixth caveat 
is that all participants were recruited from Western 
countries. It is not known how our findings relate to 
healthy cognitive performance in non-Western countries.
In sum, the studies contributing with participants to 
this study were not designed specifically to obtain stan-
dardized scores and normative data of the MCCB for 
adolescents. The scoring tables may be considered as a 
useful tool for clinicians and the scientific community, 
but the limitations discussed above should be consid-
ered when using these scores on individual patients from 
diverse backgrounds.
Conclusion
With this study, we have developed an easily accessible 
and standardized data set for healthy adolescent MCCB 
performance, which we hope will facilitate the manual 
scoring of adolescent protocols and help expand the use 
of the MCCB among children and adolescents in future 
research.
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